Glycemic control and coronary plaque characteristics in patients with acute myocardial infarction

Yuzhu Chen1, Chao Fang1, Jiawei Zhao1

  • 1Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin 150086, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China, Harbin 150086, China.

PubMed

Insights

Poor glycemic control in acute myocardial infarction (AMI) patients is linked to more vulnerable non-culprit lesions (NCLs). Higher HbA1c levels correlate with worsening plaque characteristics and increased NCL vulnerability.

Area of Science:

  • Cardiology
  • Endocrinology
  • Vascular Biology

Background:

  • The relationship between glycemic control and non-culprit lesion (NCL) morphology in acute myocardial infarction (AMI) patients is not well understood.
  • Understanding this link is crucial for predicting cardiovascular events.

Purpose of the Study:

  • To investigate the association between glycemic control, assessed by glycated hemoglobin (HbA1c) levels, and the morphological characteristics of NCLs in AMI patients.
  • To determine if poor glycemic control is an independent predictor of vulnerable plaque features in NCLs.

Main Methods:

  • 800 AMI patients were stratified into three groups based on HbA1c levels: poorly controlled diabetes mellitus (DM) (≥8.0%), well-controlled DM (6.5%–8.0%), and non-DM (<6.5%).
  • Optical Coherence Tomography (OCT) was used to assess plaque characteristics in NCLs at both patient and lesion levels, identifying high-risk features.
  • Multivariate analyses were performed to identify independent predictors of vulnerable plaque features.

Main Results:

  • Patients with poorly controlled DM exhibited significantly higher NCL vulnerability compared to well-controlled DM and non-DM groups.
  • Vulnerable plaque features, including thin-cap fibroatheroma (TCFA) and non-culprit plaque rupture (PR), were more prevalent in patients with higher HbA1c levels.
  • Poorly controlled DM was identified as an independent predictor of TCFA and microchannels at the patient level, and TCFA and non-culprit PR at the lesion level.

Conclusions:

  • Poor glycemic control is significantly associated with increased NCL vulnerability in AMI patients.
  • Increasing HbA1c levels correlate with worsening plaque characteristics, including greater plaque burden and more advanced vulnerability features.
  • These findings highlight the importance of glycemic management in mitigating cardiovascular risk in AMI patients.
Abstract